Peritoneal Carcinomatosis
by Ceelen, Wim P., M.D.Edition: 1st
Format: Hardcover
Pub. Date: 2007-05-15
Publisher(s): Springer Verlag
Other versions by this Author
List Price: $319.00
Rent Textbook
Select for Price
Rent Digital
$163.02*
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Recent developments in regional and systemic anticancer therapies have improved the grim outlook of patients with peritoneal carcinomatosis (PC) from ovarian or gastrointestinal origin, leading to a renewed interest in both the underlying mechanisms at the origin of PC and the various therapeutic options. This is the first volume to provide a multidisciplinary approach to peritoneal carcinomatosis encompassing molecular mechanisms, histopathology, regional and systemic cytotoxic therapy, and surgical options. Peritoneal Carcinomatosis: A Multidisciplinary Approach will be of interest for medical, surgical and gynecological oncologists faced with the complexities of decision making in patients suffering from PC, as well as for basic and translational scientists active in the field of locoregional cancer spread. Numerous illustrations aid the reader throughout in the many facets of this disease.
Table of Contents
| Structure and function of mesothelial cells | p. 1 |
| Molecular biology of peritoneal carcinomatosis | p. 21 |
| Role of adhesion molecules in locoregional cancer spread | p. 35 |
| Surgical trauma, minimal residual disease and locoregional cancer recurrence | p. 51 |
| Pseudomyxoma peritonei syndrome : classification of appendiceal mucinous tumours | p. 71 |
| The pathogenesis of malignant ascites | p. 109 |
| Natural history of peritoneal carcinomatosis from digestive origin | p. 119 |
| Intraperitoneal drug therapy : physical and biological principles | p. 131 |
| Current status of intraperitoneal antineoplastic drug delivery | p. 153 |
| The biologic rationale of hyperthermia | p. 171 |
| Interactions between hyperthermia and cytotoxic drugs | p. 185 |
| Pharmacodynamic aspects of intraperitoneal cytotoxic therapy | p. 195 |
| Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion | p. 215 |
| Staging and scoring of peritoneal carcinomatosis | p. 231 |
| Peritonectomy procedures | p. 247 |
| Continuous peritoneal perfusion : techniques, methods and applications | p. 265 |
| Handling of chemotherapeutic drugs in the OR : hazards and safety considerations | p. 275 |
| Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin | p. 291 |
| HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin | p. 303 |
| Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei | p. 319 |
| The impact of therapy in the treatment of pseudomyxoma peritonei | p. 329 |
| Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma | p. 343 |
| Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer | p. 357 |
| Cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian cancer | p. 375 |
| The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer | p. 387 |
| Morbidity and quality of life following cytoreduction and HIPEC | p. 403 |
| Detection and treatment of recurrent disease after cytoreduction and HIPEC | p. 419 |
| Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer | p. 425 |
| Systemic chemotherapy in patients with peritoneal carcinomatosis from non colorectal origin | p. 441 |
| The role of radiotherapy in the treatment of peritoneal carcinomatosis | p. 449 |
| Medical and palliative management of malignant ascites | p. 459 |
| Targeted intraabdominal chemotherapy for peritoneal carcinomatosis | p. 469 |
| Immunotherapy of peritoneal carcinomatosis | p. 483 |
| Intraperitoneal photodynamic therapy | p. 493 |
| Intraperitoneal gene therapy | p. 515 |
| Index | p. 525 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.